Innovative N -Acridine Thiosemicarbazones and Their Zn(II) Complexes Transmetallate with Cu(II): Redox Activity and Suppression of Detrimental Oxy-Myoglobin Oxidation
Inorganic Chemistry · 2024
DOI: 10.1021/acs.inorgchem.4c03642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2024. Verfasst von Busra Kaya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Cell Biology and Drug Discovery, Griffith University, Nathan 4111, Australia. Hauptthemen laut MEDLINE: Oxidation-Reduction, Zinc, Thiosemicarbazones, Coordination Complexes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 118 Literaturangaben. Gefördert von: National Breast Cancer Foundation, Thrasher Research Fund, National Health and Medical Research Council.
Abstract (Originalsprache)
The coordination chemistry and electrochemistry of novel N-acridine thiosemicarbazones (NATs) were investigated along with their redox activity, antiproliferative efficacy, transmetalation, and dissociation properties. The ability of NAT Fe(III) complexes to inhibit detrimental oxy-myoglobin (oxy-Mb) oxidation was also examined. The NATs act as tridentate ligands with a 2:1 L/Zn(II) complex crystal structure, revealing a distorted octahedral geometry, where both ligands bind Zn(II) in a meridional conformation. The NAT Fe(III) complexes exhibited fully reversible one-electron FeIII/II couples with more positive potentials than the Fe(III) complexes of a related clinically trialed thiosemicarbazone (e.g., [Fe(DpC)2]+) due to the electron-donating capacity of acridine. Surprisingly, the NAT-Zn(II) complexes showed generally greater or similar antiproliferative activity than their ligands, Cu(II), or Fe(III) complexes. This may be explained by (1) formation of a highly lipophilic Zn(II) complex that acts as a chaperone to promote cellular uptake and (2) the capacity of the Zn(II) complex to dissociate or undergo transmetalation to the redox-active Cu(II) complex. Of the NAT-Fe(III) complexes, [Fe(AOBP)2]+ demonstrated a significant (p < 0.0001) improvement in preventing oxy-Mb oxidation than the Fe(III) complex of the clinically trialed thiosemicarbazone, DpC. This article advances our understanding of NAT coordination chemistry, electrochemistry, and the intriguing biological activity of their complexes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Cell Biology and Drug Discovery, Griffith University, Nathan 4111, Australia.
- Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales 2006, Australia.
- Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
ORCID-Profile: Des R Richardson
Förderung
- National Breast Cancer Foundation
- Thrasher Research Fund
- National Health and Medical Research Council
- Australian Research Council
- Tour de Cure
- Griffith University
- T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu
Zitieren
APA
Kaya, B., Smith, H., Chen, Y., Azad, M. G., Russell, T. M., Richardson, V., Dharmasivam, M., & Richardson, D. R. (2024). Innovative N -Acridine Thiosemicarbazones and Their Zn(II) Complexes Transmetallate with Cu(II): Redox Activity and Suppression of Detrimental Oxy-Myoglobin Oxidation. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c03642
Vancouver
Kaya B, Smith H, Chen Y, Azad MG, Russell TM, Richardson V, et al. Innovative N -Acridine Thiosemicarbazones and Their Zn(II) Complexes Transmetallate with Cu(II): Redox Activity and Suppression of Detrimental Oxy-Myoglobin Oxidation. Inorganic Chemistry. 2024. doi:10.1021/acs.inorgchem.4c03642
BibTeX
@article{Kaya2024,
author = {Kaya, Busra and Smith, Henry and Chen, Yanbing and Azad, Mahan Gholam and Russell, Tiffany M and Richardson, Vera and Dharmasivam, Mahendiran and Richardson, Des R},
title = {Innovative N -Acridine Thiosemicarbazones and Their Zn(II) Complexes Transmetallate with Cu(II): Redox Activity and Suppression of Detrimental Oxy-Myoglobin Oxidation},
journal = {Inorganic Chemistry},
year = {2024},
doi = {10.1021/acs.inorgchem.4c03642}
}
EUVIMED